Functional analysis of choline transporters in rheumatoid arthritis synovial fibroblasts |
| |
Authors: | Masayuki Seki Yuiko Kawai Chikanao Ishii Tsuyoshi Yamanaka Masato Odawara |
| |
Affiliation: | 1. Department of Diabetes, Metabolism, Endocrinology, Rheumatology and Collagen Diseases, Tokyo Medical University, Tokyo, Japan;2. Institute of Medical Science, Tokyo Medical University, Tokyo, Japan;3. Department of Molecular Preventive Medicine, Tokyo Medical University, Tokyo, Japan |
| |
Abstract: | Objectives: In this study, we examined the functional characteristics of choline uptake and sought to identify the transporters in rheumatoid arthritis synovial fibroblasts (RASFs).Methods: The expression of choline transporters was evaluated by quantitative real-time PCR, western blotting, and immunocytochemistry. Time course, Na+-dependency, and kinetics of [3H]choline uptake were investigated. Effects of cationic drugs on the uptake of [3H]choline, cell viability, and caspase-3/7 activity were also examined. Finally, we investigated the influence of choline uptake inhibitor, hemicholinium-3 (HC-3), and choline deficiency on cell viability and caspase-3/7 activity.Results: Choline transporter-like protein 1 (CTL1) and CTL2 mRNA and protein were highly expressed in RASFs and were localized to the plasma membrane. [3H]Choline uptake occurred via a Na+-independent and pH-dependent transport system. The cells have two different [3H]choline transport systems, high- and low-affinity. Various organic cations, HC-3 and choline deficiency inhibited both [3H]choline uptake and cell viability, and enhanced the caspase-3/7 activity. The functional inhibition of choline transporters could promote apoptotic cell death. In RASFs, [3H]choline uptake was significantly increased compared with that in OASFs without a change in gene expression.Conclusions: These results suggest that CTL1 (high-affinity) and CTL2 (low-affinity) are highly expressed in RASFs and choline may be transported by a choline/H+?antiport system. Identification of this CTL1- and CTL2-mediated choline transport system should provide a potential new target for RA therapy. |
| |
Keywords: | Choline transporter rheumatoid arthritis synovial fibroblasts (RASFs) apoptosis |
|
|